Last reviewed · How we verify

NCT06291727

Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA

Completed Phase 4 Last updated 28 August 2025
What this trial tests

Phase 4 trial testing Mepivacaine in Anesthesia, Spinal in 138 participants. Completed in 1 August 2025.

Timeline
16 February 2024
Primary endpoint
1 August 2025
1 August 2025

Quick facts

Lead sponsorPrisma Health-Upstate
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment138
Start date16 February 2024
Primary completion1 August 2025
Estimated completion1 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Prisma Health-Upstate — full company profile →

Who can join

18 and older, any sex, with Anesthesia, Spinal or Arthroplasty, Replacement, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, double-blind prospective randomized controlled trial comparing mepivacaine and bupivacaine spinal anesthesia for same-day discharge readiness following a unilateral primary elective TKA procedure. Study data will be collected during the patient's hospital stay for their TKA procedure, and the primary outcome of same-day discharge readiness will be assessed the day of surgery. Patients will also be contacted at Day 3 post-op to assess for any complications, current level of pain, and pain medication utilization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mepivacaine

Trials testing the same drug.

Other recruiting trials for Anesthesia, Spinal

Currently open trials in the same condition.

Other Prisma Health-Upstate trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06291727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing